Illumina, Inc. (NASDAQ: ILMN) today introduced Nextera Exome and Custom
Enrichment kits, the Company's latest targeted resequencing solutions
offering sample preparation and enrichment in a single, integrated
workflow. Leveraging the speed of Nextera technology and supporting the
industry's lowest DNA sample input requirements (50 ng), the new kits
enable researchers to quickly and economically perform a wide range of
studies - from small, focused gene panels to full human exomes.
Upfront sample preparation is an often difficult and time-consuming task
for targeted resequencing studies. Nextera Exome and Custom Enrichment
kits replace the lengthy sample preparation protocols with a single,
streamlined workflow that can be performed in less than three hours and
removes the requirement for mechanical DNA fragmentation. The kits
integrate the ease of Nextera sample preparation with the company's
established TruSeq® Exome and Custom Enrichment solutions for a
fast, scalable and highly efficient approach to targeted resequencing.
Offering excellent data quality with a low DNA sample input requirement,
the kits enable researchers to study small samples, while retaining
sufficient material for future analysis.
"Nextera Enrichment kits deliver superior performance on all fronts with
a simple, rapid workflow that eliminates almost an entire day of
preparation time," said Christian Henry, Senior Vice President and
General Manager, Genomic Solutions. "Developed, tested, and optimized
for Illumina sequencing platforms, Nextera Enrichment kits make targeted
resequencing more broadly available to researchers who are interested in
performing studies on DNA samples that may only be available in limited
quantities."